↓ Skip to main content

Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data

Overview of attention for article published in BMC Clinical Pharmacology, June 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

patent
1 patent

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
24 Mendeley
Title
Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data
Published in
BMC Clinical Pharmacology, June 2012
DOI 10.1186/1472-6904-12-12
Pubmed ID
Authors

Vivienne J Zhu, Anne Belsito, Wanzhu Tu, J Marc Overhage

Abstract

Observational data are increasingly being used for pharmacoepidemiological, health services and clinical effectiveness research. Since pharmacies first introduced low-cost prescription programs (LCPP), researchers have worried that data about the medications provided through these programs might not be available in observational data derived from administrative sources, such as payer claims or pharmacy benefit management (PBM) company transactions.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 4%
Unknown 23 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 25%
Other 3 13%
Student > Master 3 13%
Student > Doctoral Student 1 4%
Student > Bachelor 1 4%
Other 4 17%
Unknown 6 25%
Readers by discipline Count As %
Medicine and Dentistry 6 25%
Pharmacology, Toxicology and Pharmaceutical Science 4 17%
Business, Management and Accounting 2 8%
Agricultural and Biological Sciences 1 4%
Social Sciences 1 4%
Other 1 4%
Unknown 9 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2023.
All research outputs
#7,752,409
of 23,572,442 outputs
Outputs from BMC Clinical Pharmacology
#27
of 58 outputs
Outputs of similar age
#55,608
of 165,596 outputs
Outputs of similar age from BMC Clinical Pharmacology
#1
of 3 outputs
Altmetric has tracked 23,572,442 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 58 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 165,596 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them